HCA Healthcare price target raised to $392 from $335 at Cantor Fitzgerald

Cantor Fitzgerald raised the firm’s price target on HCA Healthcare (HCA) to $392 from $335 and keeps an Overweight rating on the shares. The firm recently increased 2025E revenue estimates by $1.6B to $73.9B from $72.3B, and 2025E adjusted EBITDA estimates to $14.6B from $14.1B and has an increasingly positive outlook on the hospital industry post Tenet’s (THC) commentary on the duration of inpatient admission trends’ sustainability, the analyst tells investors in a research note.